| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 08/04/2005 | US20050171701 System and method for identifying, reporting, and evaluating presence of substance |
| 08/04/2005 | US20050171340 Compounds and methods for fluorescent labeling |
| 08/04/2005 | US20050171338 Mammalian tribbles signaling pathways and methods and reagents related thereto |
| 08/04/2005 | US20050171336 Murine ortholog of the human disrupted-in-schizophrenia 1 gene |
| 08/04/2005 | US20050171202 Modulation of signal transduction |
| 08/04/2005 | US20050171069 Methods and reagents for the treatment of multiple sclerosis |
| 08/04/2005 | US20050171043 Methods and compositions for modulating mitochondrial aldehyde dehydrogenase-2 |
| 08/04/2005 | US20050171024 Modulating angiogenesis |
| 08/04/2005 | US20050171000 computer aided drug design; e.g. candidate drugs to treat obesity |
| 08/04/2005 | US20050170976 Oil composition and method of detecting a marker in an oil composition |
| 08/04/2005 | US20050170553 Apparatus for controlled alignment of catalytically grown nanostructures |
| 08/04/2005 | US20050170528 Computer model for prognosticating/diagnosing clincal outcomes based of clustered genomic data points |
| 08/04/2005 | US20050170527 Quantitative lateral flow assays and devices |
| 08/04/2005 | US20050170526 Utilizing affinity capture to isolate the analytes and internal reference species (for quantification) followed by mass spectrometric analysis of the isolated analyte/internal reference species. |
| 08/04/2005 | US20050170519 Agent for protein precipitation, a method of protein precipitation, a method of protein assay using protein precipitation agent, and a kit for protein assay |
| 08/04/2005 | US20050170517 Materials for enhancing staining of biopolymers in matrices |
| 08/04/2005 | US20050170516 Compositional characterization and quantification of solid deposits from hydrocarbon fluids |
| 08/04/2005 | US20050170496 Method for processing a nucleic acid sample by oscillating a cartridge, a system and a cartridge for performing such a method |
| 08/04/2005 | US20050170494 Plasmon resonance having layer of anodized or oxidized alumina with a plurality of independent pores filled with gold or silver metallic particles; refractive index detectors |
| 08/04/2005 | US20050170483 Preparing ethanol, in bioreactor comprising oscillatory components, from enzyme mixture |
| 08/04/2005 | US20050170448 For use in ionophoretic devices; glucose oxidoreductases; mutarotases |
| 08/04/2005 | US20050170447 Reagent combination and method for direct test strip measurement of cholesterol from low density lipoproteins at ambient temperatures |
| 08/04/2005 | US20050170446 Solid support comprising immobilized biopolymers for detection of preferential compounds in biological fluids; bioassay |
| 08/04/2005 | US20050170445 Methods of establishing profiles for use in evaluating wound healing and biocompatibility of implant materials and microarrays useful therefor |
| 08/04/2005 | US20050170444 Detecting levels of free placental growth factor in urine samples; enzyme-lined immunosorbent assay, fluorescence polarization assay, or a colorimetric assay |
| 08/04/2005 | US20050170443 Methods and use of binding components for improving assay specificity |
| 08/04/2005 | US20050170442 Bimolecular optical probes |
| 08/04/2005 | US20050170441 Early detection of cancer of specific type using 1HNMR metabonomics |
| 08/04/2005 | US20050170440 Treatment and diagnosis of insulin-resistant states |
| 08/04/2005 | US20050170439 Using epidermal growth factor receptor complexes to diagnose and prognose health in cancer patients; drug screening; phosphatidyl inositol 3 kinase (pi3k) |
| 08/04/2005 | US20050170438 Epidermal growth factors; ERBB/HER genes/proteins; electrophoresis; cancer biopsies |
| 08/04/2005 | US20050170437 Methods and compositions relating to modulating amyloid precursor protein cleavage |
| 08/04/2005 | US20050170435 Heterotrimeric G protein/fluorescent protein fusion for monitoring and screening efficacy of drugs |
| 08/04/2005 | US20050170434 Modulators of lymphocyte activation, mkk3b compositions and methods of use |
| 08/04/2005 | US20050170433 Three dimensional coordinates of melanin-concentrating hormone receptors |
| 08/04/2005 | US20050170431 PYK2 crystal structure and uses |
| 08/04/2005 | US20050170430 Diagnosis and treatment of glaucoma and methods for discovering new glaucoma therapeutic agents based on the wnt/ca2+ signaling pathway |
| 08/04/2005 | US20050170429 Method for monitoring collagen type II degradation in cartilage |
| 08/04/2005 | US20050170427 For activated slides for preparing microarrays of nucleic acids; solid phase synthesis |
| 08/04/2005 | US20050170426 Device for binding molecules, molecular groups, molecular parts and/or cells |
| 08/04/2005 | US20050170425 Hybridizing microorganism cDNA with probes linked to magnetic bead within tube, transferring to magnetic wells for washing, adding blocking solution, adding avidin enzyme complex or streptavidin enzyme complex, rewashing, suspending magnetic beads, and detecting luminescence or color change; kits |
| 08/04/2005 | US20050170423 Systems and methods for transgenic and targeted mutagenesis screening |
| 08/04/2005 | US20050170417 A mutated G-CSF protein having a deletion of an amino acid sequence corresponding to an exon 3 region for use as a diagnostic cancer marker. |
| 08/04/2005 | US20050170416 Accurate, economical and simple diagnosis of a variety of cancers based on the finding that exon 3 skipping occurs during transcription of the G-CSF gene in cancer patients |
| 08/04/2005 | US20050170413 Transport peptide amino acid sequences for use in identifying modulators for prevention and treatment of cell proliferative disorders; tissue target therapy; drug delivery |
| 08/04/2005 | US20050170412 Microarray for detection of sequence anomalies in preferential genes; genomics |
| 08/04/2005 | US20050170408 Recombinant g protein coupled receptor for use in identifying modulators for prevention and treatment of cell proliferative disorders |
| 08/04/2005 | US20050170407 Reagents and methods useful for detecting diseases of the lung |
| 08/04/2005 | US20050170406 Using Burkitt's lymphoma-172 nucleotide sequences as diagnostic, prognostic and imaging tool in detection and treatment of infection and cell proliferative disorders of urogenital system |
| 08/04/2005 | US20050170404 Modified human growth hormone polypeptides and their uses |
| 08/04/2005 | US20050170400 Using colorimetric analysis to determine positioning of coded beads in capillary system; biochips for biopolymer detection |
| 08/04/2005 | US20050170396 Using monoclonal antibodies to determine concentration of preferential membrane bound receptor in cancer cells; immunoassay |
| 08/04/2005 | US20050170394 GLUT1 transporters expressed in blood brain barrier cells |
| 08/04/2005 | US20050170393 Using organic anion transporter polypeptide-related protein (OATPB) as diagnostic tool in detecting modulators for prevention and treatment of nervous system disorders |
| 08/04/2005 | US20050170392 OAT3 transporters expressed in blood brain barrier cells |
| 08/04/2005 | US20050170391 TAUT1 transporters expressed in blood brain barrier cells |
| 08/04/2005 | US20050170390 MCT1 transporters expressed in blood brain barrier cells |
| 08/04/2005 | US20050170385 Artificial receptors including gradients |
| 08/04/2005 | US20050170383 Microarray hybridization assembly using a heat shrinkage bag for sealing the reaction region |
| 08/04/2005 | US20050170379 Using genic variation to generate preferential therpeutics; bioinformatics; computtation models for rational drug design |
| 08/04/2005 | US20050170378 Using comparative genomic hybridization to co-analyze DNA copy number and gene expression data to identify significant relationships between alterations in genomic sequence and genic function; genomics; proteomics; bioinformatics |
| 08/04/2005 | US20050170373 Expression profiling using microarrays |
| 08/04/2005 | US20050170372 Using computer systems monitor, categorize and classify genetic, protein and metabolic components of cell systems; proteomics; genomics; bioinformatics |
| 08/04/2005 | US20050170370 Microarray comprising immobilized primers for monitoring RNA expression; transcrptional analysis |
| 08/04/2005 | US20050170369 Methods for diagnosing a genetic risk for bone loss |
| 08/04/2005 | US20050170368 Tumor-associated antigenic target polypeptides for use as tools in treatment of cell proliferative disorders; antitumor and/or antiproliferative agents |
| 08/04/2005 | US20050170363 For conjugation with biomolecules, drugs, and toxins |
| 08/04/2005 | US20050170362 Reduction of migration shift assay interference |
| 08/04/2005 | US20050170361 Method of preparing reaction regions for biochips |
| 08/04/2005 | US20050170360 nicotinic acetylcholine receptor treating and preventing nervous system and neurodegenerative diseases; neuroprotectant; cytoprotective agents |
| 08/04/2005 | US20050170359 Treatment of vascular dysfunction and alzheimer's disease |
| 08/04/2005 | US20050170356 Multi-reagent pack |
| 08/04/2005 | US20050170353 Using allelic variation in myocilin (MYOC) gene as prognostic/diagnostic tool in detection of vision defects |
| 08/04/2005 | US20050170352 Use of biomarkers to detect breast cancer |
| 08/04/2005 | US20050170351 Using estrogen receptor and oncogenic transmembrane receptor profiles as diagnostic/prognostic tool in detection of cell proliferative disorders |
| 08/04/2005 | US20050170349 A purified polypeptide comprising a splice variant of AMP-activated kinase; a nucleic acid and expression vector; bioassay for modulators; antibodies for the polypeptide; improved metabolic regulation |
| 08/04/2005 | US20050170345 Using neuronal tissue as models in identifying agents which promote neuronal survival during hypoxic-ischemic events; antiischemic agents |
| 08/04/2005 | US20050170344 Chds as modifiers of the p53 pathway and methods of use |
| 08/04/2005 | US20050170343 Modulating insulin receptor signaling |
| 08/04/2005 | US20050170333 Identification of etiology of autism |
| 08/04/2005 | US20050170332 Using fluorescence and time-based image capturing to monitor activities in cell |
| 08/04/2005 | US20050170331 Method for characterizing metabolic stability of a drug |
| 08/04/2005 | US20050170330 Using transgenic angiogenic progenitor cells to diagnosis neovascularization and tumor development |
| 08/04/2005 | US20050170329 Screening assays using intramitochondrial calcium |
| 08/04/2005 | US20050170328 Process for the monitoring of contaminant removal during the purification process of a pharmaceutical product produced by a host cell |
| 08/04/2005 | US20050169993 Sustained-release formulation |
| 08/04/2005 | US20050169982 Topiramate sodium, topiramate lithium, topiramate potassium, or polymorphs, solvates, hydrates, dehydrates, co-crystals, anhydrous, and amorphous forms; seizures, obesity, neuropathic pain, affective disorders, tobacco cessation, chronic fatigue syndrome, drug addiction; highly soluble, bioavailability |
| 08/04/2005 | US20050169962 Selective photopolymerization of biopolymers to create patterned structures and the patterning of cells within relatively homogenous slabs of biopolymer using dielectrophoresis; use as bioreactors, in bioassays, making artificial cartilage, or providing hepatic support |
| 08/04/2005 | US20050169937 Attacking immune tolerant species; having at least one consensus amino acid sequence |
| 08/04/2005 | US20050169934 Computer assisted modeling of tumor antigen bound in major histocompatibility complex I groove; substituting at least first amino acid located in cytotoxic T lymphocyte epitope; reducing interference with T cell receptor binding; HER-2 related cancer |
| 08/04/2005 | US20050169930 PSCA: prostate stem cell antigen and uses thereof |
| 08/04/2005 | US20050169925 variable regions peptides for immunizing against amyloid plaque formation; biodrug for dementia, Alzheimer's disease, neuropathy, Down's syndrome, Creutzfeld Jacob disease, Parkinson's disease, amyotropic lateral sclerosis; neuroprotectants; hemostatic agent |
| 08/04/2005 | US20050169923 monoclonal antibody prevents the growth or differentiation of the B cell; secreted by the hybridoma; therapy of autoimmune diseases, sytematic lupus erythematosus, primary biliary cirrhosis, and idiopathic thrombocytopenic purpura; biodrug |
| 08/04/2005 | US20050169920 Pecam-1 modulation |
| 08/04/2005 | US20050169913 Administering a monoclonal antibody or enzyme inhibitor of prothrombinase; therapeutic treatment of bacterial and viral infections, allograft and xenograft rejection, cancer, glomerulonephritis, gastrointestinal disorders and fetal loss; inhibiting gene expression of prothrombinase |
| 08/04/2005 | US20050169911 Monoclonal antibody recognizing phosphatidylinositol-3,4,5-triphosphate |
| 08/04/2005 | US20050169901 controlling cytokine levels by administering extract or secreted products from microorganism; biosynthesis; atheroma, degenerative vascular disease or cardiovascular disease associated with inflammation of the coronary arteries; hypotensive agents, antilipemic agents, anticholesterol agents |
| 08/04/2005 | US20050169898 Fusion of dendritic cells and antigen presenting cells; immunotherapy for stimulating an immune system; hybride cells; genetic engineering |
| 08/04/2005 | US20050169853 Synthetic peptides containing protective epitopes for the treatment and prevention of periodontitis associated with Porphyromonas gingivalis |
| 08/04/2005 | US20050169841 Methods of screening for B cell activity modulators |